Barbier L - Search Results

1

Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance.

Meijboom RW, Barbier L, Druedahl LC, Sarnola K, Tolonen HM, Gardarsdottir H, Egberts TCG, Giezen TJ. Meijboom RW, et al. Among authors: barbier l. Expert Opin Biol Ther. 2023 Jul-Dec;23(8):801-817. doi: 10.1080/14712598.2023.2189008. Epub 2023 Mar 23. Expert Opin Biol Ther. 2023. PMID: 36947408 Free article.

2

Community pharmacists' preparedness for substituting biologics and dispensing biosimilars - Lessons learned from a multinational survey.

Arnet I, Verbeek M, Almarsdóttir Anna B, Barbier L, Clifford R, Eickhoff C, Hersberger K, Huys I, Lee K, Saramunee K, Schulz M, Zgarrick D, Sarnola K. Arnet I, et al. Among authors: barbier l. Explor Res Clin Soc Pharm. 2021 Oct 22;4:100084. doi: 10.1016/j.rcsop.2021.100084. eCollection 2021 Dec. Explor Res Clin Soc Pharm. 2021. PMID: 35479848 Free PMC article.

3

European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical Practice.

Barbier L, Simoens S, Vulto AG, Huys I. Barbier L, et al. BioDrugs. 2020 Dec;34(6):797-808. doi: 10.1007/s40259-020-00440-z. BioDrugs. 2020. PMID: 33063267 Free PMC article.

4

European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and Adoption.

Barbier L, Simoens S, Vulto AG, Huys I. Barbier L, et al. BioDrugs. 2020 Dec;34(6):783-796. doi: 10.1007/s40259-020-00452-9. BioDrugs. 2020. PMID: 33141421 Free PMC article. Review.

5

Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care.

Vandenplas Y, Barbier L, Simoens S, Van Wilder P, Vulto AG, Huys I. Vandenplas Y, et al. Among authors: barbier l. Front Pharmacol. 2022 Jan 5;12:789640. doi: 10.3389/fphar.2021.789640. eCollection 2021. Front Pharmacol. 2022. PMID: 35069205 Free PMC article.

6

Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging.

Barbier L, Mbuaki A, Simoens S, Declerck P, Vulto AG, Huys I. Barbier L, et al. Front Med (Lausanne). 2022 Mar 9;9:820755. doi: 10.3389/fmed.2022.820755. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35355594 Free PMC article.

7

Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking.

Barbier L, Simoens S, Declerck P, Vulto AG, Huys I. Barbier L, et al. Front Pharmacol. 2022 Jul 12;13:821616. doi: 10.3389/fphar.2022.821616. eCollection 2022. Front Pharmacol. 2022. PMID: 35903323 Free PMC article.

8

Informing a European guidance framework on electronic informed consent in clinical research: a qualitative study.

De Sutter E, Borry P, Huys I, Barbier L. De Sutter E, et al. Among authors: barbier l. BMC Health Serv Res. 2023 Feb 21;23(1):181. doi: 10.1186/s12913-023-09173-5. BMC Health Serv Res. 2023. PMID: 36810088 Free PMC article.

9

Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment: An ISPOR Special Interest Group Report.

Barcina Lacosta T, Inotai A, Pereira CL, Barbier L, Simoens S. Barcina Lacosta T, et al. Among authors: barbier l. Value Health. 2024 May;27(5):543-551. doi: 10.1016/j.jval.2024.01.018. Value Health. 2024. PMID: 38702140

10

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars.

Barbier L, Declerck P, Simoens S, Neven P, Vulto AG, Huys I. Barbier L, et al. Br J Cancer. 2019 Jul;121(3):199-210. doi: 10.1038/s41416-019-0480-z. Epub 2019 Jul 1. Br J Cancer. 2019. PMID: 31257362 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters